BioCentury
ARTICLE | Company News

Basilea, Hikma Pharmaceuticals deal

November 16, 2015 8:00 AM UTC

Basilea granted Hikma exclusive rights to commercialize Zevtera ceftobiprole in the Middle East and North Africa. The antibiotic is approved in Europe to treat adults with community-acquired pneumoni...